Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.
The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. The company also provides VAAST (Vector-Adjuvant-Antigen Standardized Technology) Platform, a unique modular vaccine platform. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
Company profile from EODHD, stored Oct 25, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 6, 2026 | $27.2M | -31.6% | 100.0% | -$13.2M | -$13.5M |
| Mar 2026filed May 7, 2026 | $39.2M | +87.9% | 100.0% | $5.2M | $5.2M |
| Dec 2025filed Mar 13, 2026 | $104.2M | +586.5% | — | $55.4M | $55.0M |
| Sep 2025filed Nov 13, 2025 | $72.4M | +1,367.9% | 100.0% | -$7.8M | -$8.1M |
| Jun 2025filed Aug 13, 2025 | $39.7M | +520.7% | 100.0% | -$14.6M | -$15.0M |
| Mar 2025filed May 13, 2025 | $20.9M | +857.2% | 100.0% | -$14.9M | -$15.6M |
| Dec 2024filed Mar 20, 2025 | $15.2M | +368.0% | — | -$11.5M | -$12.0M |
| Sep 2024filed Nov 13, 2024 | $4.9M | +134.8% | 100.0% | -$14.5M | -$14.1M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 13, 2026 | — | — | — | — | — |
| Dec 2024filed Mar 20, 2025 | $28.7M | +288.9% | — | -$66.3M | -$66.9M |
| Dec 2023filed Mar 14, 2024 | $7.4M | +6,796.3% | 39.0% | -$83.3M | -$82.5M |
| Dec 2022filed Mar 15, 2023 | $107.0K | -88.0% | — | -$114.6M | -$107.8M |
| Dec 2021filed Feb 24, 2022 | $892.0K | -78.0% | -5,365.1% | -$72.8M | -$70.5M |
| Dec 2020filed Feb 25, 2021 | $4.0M | -59.0% | -390.9% | -$30.2M | -$32.2M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched VXRT. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
2,404,459 shares short
+77,503 shares (+3.3%) vs Sep 30, 2026
1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,326,956 shares short
+20,301 shares (+0.9%) vs Sep 15, 2026
1% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,306,655 shares short
-5,317 shares (-0.2%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
2,311,972 shares short
-22,287 shares (-1%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
2,334,259 shares short
-124,366 shares (-5.1%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
2,458,625 shares short
-112,984 shares (-4.4%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind VXRT’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
The newest stored ex-date is Nov 9, 2012. These are historical records; a current dividend schedule is unavailable.
USD 1.108 per share
Ex-dividend date: Nov 9, 2012
Recorded pay date: Nov 8, 2012 (past date)
Cash dividend · Polygon event record
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 11 · reverse split
Effective Feb 14, 2018
Each 11 pre-split shares become 1 post-split share.
Source: EODHD
1 for 6 · reverse split
Effective Nov 9, 2012
Each 6 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if VXRT is in your portfolio and how much it contributes.
Sign inLoading market dates
0 smart-money holders: institutions with a high Holder IQ
Sentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 8
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
4 filers reported a long position in VXRT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 4 hold
100%
of the 64.7K shares 13-F filers reported
Moves vs Q1 2026
No comparable changes
1 new · 2 unchanged · 1 not comparable
Net shares held
Unchanged
across the 2 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Heritage Wealth Advisors | $17.9K · 29.7K shares | 29.7K | Unchanged |
| 2 | LVM CAPITAL MANAGEMENT LTD/MI | $15K · 25K shares | 25K | — |
| 3 | KINGSWOOD WEALTH ADVISORS, LLC | $6.1K · 10K shares | 10K | New |
| 4 | Archer Investment Corp | $9 · 15 shares | 15 | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inUnlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.